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Summary
Inflammatory processes play an important role in the pathogenesis of vascular diseases, and insulin-resistant diabetesmel-
litus type 2 represents an important risk factor for the development of atherosclerosis. To directly address the role of insulin
resistance in myeloid lineage cells in the development of atherosclerosis, we have created mice with myeloid lineage-
specific inactivation of the insulin receptor gene. On an ApoE-deficient background, MphIRKO mice developed smaller
atherosclerotic lesions. There was a dramatic decrease in LPS-stimulated IL-6 and IL-1b expression in the presence of
macrophage autonomous insulin resistance. Consistently, while insulin-resistant IRS-2-deficient mice on an ApoE-
deficient background display aggravated atherosclerosis, fetal liver cell transplantation of IRS-22/2ApoE2/2 cells amelio-
rated atherosclerosis in Apo-E-deficientmice. Thus, systemic versusmyeloid cell-restricted insulin resistance has opposing
effects on the development of atherosclerosis, providing direct evidence that myeloid lineage autonomous insulin signaling
provides proinflammatory signals predisposing to the development of atherosclerosis.Introduction
Type 2 diabetes mellitus represents a frequent endocrine dis-
ease, affecting more than 5% of Western populations (Engelgau
et al., 2004). Besides the direct consequences on glucose me-
tabolism, insulin resistance is associated with a number of car-
diovascular risk factors, such as obesity, dyslipoproteinemia,
hypertension, and accelerated atherosclerosis (Reaven, 2004).
Diabetic patients and individuals with the metabolic syndrome
show an increased rate of both myocardial infarction and stroke
(Reaven, 2004). Conversely, consequent insulin treatment of pa-
tients suffering from acute myocardial infarction improves their
survival (Malmberg et al., 1995).
Beside the well-characterized cardiovascular risk factors as-
sociated with insulin resistance, insulin receptors are expressed
and functional in many cell types implicated in the pathogenesis
of atherosclerosis, including endothelial cells, vascular smooth
muscle cells, and macrophages (Baudler et al., 2003). Through
the use of Cre-loxP-mediated conditional inactivation of the in-
sulin receptor in vascular endothelial cells, we could demon-
strate that functional insulin signal transduction in this cell type
is required for expression of vasoactive mediators and may
play a role in maintaining vascular tone and regulation of insulin
sensitivity to dietary salt intake (Vicent et al., 2003).
Consistent with the clinical association of insulin resistance,
type 2 diabetes and atherosclerosis mouse models of insulin re-
sistance such as insulin receptor substrate (IRS)-2-deficientCELL METABOLISM 3, 247–256, APRIL 2006 ª2006 ELSEVIER INC. Dmice exhibit increased neointima formation after vessel injury
and increased neointima lipid accumulation on an ApoE-
deficient background (Kubota et al., 2003; Clough et al., 2005).
Considerable recent evidence has demonstrated that inflam-
matory processes, in particular macrophages and foam cells
play a key role in the pathogenesis of atherosclerosis (Libby,
2002). However, the direct role of insulin signaling in myeloid lin-
eage cells remains controversial. Insulin acutely stimulates ex-
pression of tumor necrosis factor (TNF)-a in immortalizedmurine
macrophages and enhances LPS-stimulated transcription of
TNF-a, interleukin (IL)-6, and IL-1b, characterizing insulin as a
proinflammatory signal in macrophages (Holan and Minowada,
1992; Iida et al., 2001). On the other hand, insulin negatively reg-
ulates NFkB-activation and the generation of reactive oxygen
species in monocytes, pointing to a role as an anti-inflammatory
signal (Dandona et al., 2001). A role for insulin in the regulation of
macrophage lipid metabolism has also been suggested from its
transcriptional control of hormone sensitive lipase and ACAT
and the translational control of CD36-expression (Liang et al.,
2004; O’Rourke et al., 2002). Taken together, there is experi-
mental evidence that insulin through its receptors is involved
in the regulation of key processes in macrophages implied in
the development of atherosclerosis. To directly address the
role of insulin signaling in myeloid lineage cells, we have used
two models of myeloid cell-restricted insulin resistance, i.e.,
macrophage-specific insulin receptor knockout mice and mice
lacking IRS-2 in hematopoetic cells by adoptive transfer ofOI 10.1016/j.cmet.2006.02.010 247
A R T I C L EIRS-22/2ApoE2/2 fetal liver cells (FLCs) in irradiated ApoE2/2
mice. Moreover, we have compared the effect of myeloid cell-
restricted IRS-2 deficiency to body-wide IRS-2 deficiency on
the development of atherosclerosis on an ApoE-deficient back-
ground.
Results
Generation of MphIRKO mice
To specifically inactivate the insulin receptor gene in myeloid lin-
eage cells, mice carrying an insulin receptor floxed allele (IRflox)
were bred with mice expressing the Cre recombinase under
control of the Lysozyme M promoter. Double-heterozygous
mice were intercrossed to obtain IRflox/flox and IRflox/flox
LysCre+/2, i.e., MphIRKO mice. Inactivation of the IR in mice
carrying the LysMCre transgene and homozygous for the IRflox
allele by Western blot analysis of thioglycollate (TG)-elicited
macrophages of control and MphIRKO mice was >90% (Fig-
ure 1A). Similarly, recombination of the IRflox allele occurred
with 90% efficiency in TG macrophages from MphIRKO mice
(Figure 1A). This parallels the percentage of macrophages ob-
tained by this procedure as analyzed by FACS analysis using
anti-CD19 and anti-MAC1 antibodies (Figure 1A). To investigate
the specificity of the myeloid lineage-restricted insulin receptor
knockout in MphIRKO mice, we performed Western blot analy-
ses on tissue extracts from a variety of different nonmyeloid lin-
eage cells such as white adipose tissue, liver, skeletal muscle,
kidney, and brain. This analysis revealed unaltered insulin re-
ceptor expression in these tissues ofMphIRKOmice (Figure 1B).
Taken together, we achieved efficient, macrophage-specific in-
activation of the insulin receptor gene in MphIRKO mice.
Myeloid lineage-specific deletion of the insulin receptor gene
had no impact on growth and development of MphIRKO mice.
Both growth curves of control andMphIRKOmice were indistin-
guishable as were plasma leptin and insulin concentrations and
white adipose tissue mass (data not shown). Moreover, glu-
cose-tolerance tests and insulin-tolerance tests revealed unal-
tered glucose homeostasis in these animals (data not shown).
Amelioration of atherosclerotic lesions
in MphIRKO/ApoE2/2 mice
To analyze the impact of macrophage insulin signaling on the
development of atherosclerosis, we crossed the MphIRKO
mice on an ApoE-deficient background. Also IRflox/floxApoE2/2
and IRflox/floxLysMCre+/2ApoE2/2 mice were indistinguishable
with respect to body weight and glucose metabolism (data not
shown).
Atherosclerotic lesion size was quantified in the descending
aorta of male IRflox/flox ApoE2/2 and IRflox/floxLysMCre+/2
2ApoE2/2 mice at the age of 5 months after 4 months of expo-
sure to a high-cholesterol diet. This analysis revealed a signifi-
cant w50% reduction in lesion size in the presence of macro-
phage-specific insulin resistance (Figure 2A). Importantly, also
under high-cholesterol diet conditions there was no difference
between IRflox/floxApoE2/2 and IRflox/floxLysMCre+/2ApoE2/2
mice with respect to plasma glucose, insulin, and cholesterol
concentrations (Figure 2B). Moreover, lipoprotein profiles did
not differ depending on macrophage insulin receptor expres-
sion, again ruling outmajormetabolic alterations in the presence
of macrophage-specific insulin resistance leading to the reduc-
tion of atherosclerosis (Figure 2C).248Unaltered metabolism of modified LDL particles
in MphIRKO mice
Since macrophages play an important role in the metabolism
of modified LDL particles, we next determined the expression
and function of scavenger receptors in the macrophages of
MphIRKO mice. Uptake of oxidized LDL is mainly mediated by
the scavenger receptor CD36. Recently, it has been demon-
strated that macrophage insulin signaling regulates protein ex-
pression of CD36 through translational control mechanisms
(Liang et al., 2004). Therefore, we determined both expression
of CD36 mRNA by Northern blot analysis and CD36 protein ex-
pression by Western blot analysis in thioglycollate-elicited pri-
mary macrophages and in immortalized control and IR-deficient
macrophage cell lines. In order to obtain an in vitro culture sys-
tem for the analysis of insulin receptor function in macrophages,
we immortalized macrophage cell lines by retroviral transduc-
tion of bone marrow precursor cells from IRflox/flox mice. FACS
analysis of these cell lines revealed a macrophage phenotype
as assessed by staining with anti-MAC1 and F4/80 antibodies,
Figure. 1. Effective and selectivemyeloid lineage-specific inactivation of the insu-
lin receptor gene in MphIRKO–mice
A) PCR analysis of Cre-mediated recombination in thioglycollate-elicited macro-
phages from IRflox/flox (WT) and IRflox/floxLysMCre+/2 (KO) mice. The upper-right
panel shows the percentage of macrophages (MAC1 positive, CD19 negative)
present in peritoneal lavage after thioglycollate treatment by FACS analysis using
CD19 and MAC1-antibodies. The lower panel shows the expression of the insulin
receptor b subunit in thioglycollate-elicited macrophages from four individual wild-
type and knockout mice. The lower panel shows a Western blot analysis against
the chemokine receptor CCR-1, serving as a loading control.
B) Western blot analysis of the insulin receptor b subunit in white adipose tissue
(WAT), liver, brain, skeletal muscle, and kidney of IRflox/flox (WT) and IRflox/flox
LysMCre+/2 (KO) mice.CELL METABOLISM : APRIL 2006
Macrophage-specific insulin resistanceFigure 2. Reduced atherosclerosis in ApoE-defi-
cient MphIRKO mice
A) Representative Sudan IV stainings ofmaleApoE2/2
IRflox/flox and ApoE2/2IRflox/floxLysMCre+/2mice under
high-cholesterol diet and quantitation of lesion size
in the descending aorta ofmaleApoE2/2IRflox/flox (con-
trol) and ApoE2/2IRflox/floxLysMCre+/2 (MphIRKO)
mice. Data represent the mean of six to nine animals
of each genotype (*p < 0.05 in unpaired Student’s
t test).
B)Plasmaglucose, insulin, and cholesterol concentra-
tions were determined in male ApoE2/2IRflox/flox (con-
trol) and ApoE2/2IRflox/floxLysMCre+/2 (MphIRKO)
mice exposed to high-cholesterol diet at the age of
5 months after overnight fasting. Data represent the
mean6 SEM of six to nine animals of each genotype.
C)LipoproteinprofilesasdeterminedbyFPLCanalysis
from pooled sera of male ApoE2/2IRflox/flox (red line)
and ApoE2/2IRflox/flox LysMCre +/2 (green line) mice.while the cells were negative for the B-cell marker CD19 (data
not shown). To circumvent potential problems arising from dif-
ferences between cell lines obtained from individual control
and MphIRKOmice, we decided to acutely inactivate the insulin
receptor gene in immortalized macrophages derived from
IRflox/flox mice. Therefore, these cells were cultured overnight
in the presence of a recombinant fusion protein of the Cre-re-
combinase and the protein transduction domain of the HIV-Tat
protein. In vitro transduction of the IRflox/flox cells resulted in
complete recombination of the IRflox allele and abolishment of
IR expression, as assessed by Western blot analysis (data not
shown).
Analysis of CD36 mRNA and protein expression revealed no
alterations in insulin receptor-deficient macrophages (Fig-
ure 3A). Since it had been demonstrated that in other tissues,
such as adipose and cardiac muscle, insulin is capable of
acutely stimulating translocation of CD36 to the plasma mem-
brane (Luiken et al., 2002), we determined the expression ofCELL METABOLISM : APRIL 2006CD36 on the plasma membrane by FACS analysis. When
plasma membrane CD36 expression was analyzed, cell surface
expression of CD36 was indistinguishable between control and
IR-deficient macrophages (Figure 3B). Also, cell surface expres-
sion of the alternative scavenger receptor CD204 was unaltered
in the presence of macrophage-specific insulin resistance (data
not shown). Moreover, analysis of mRNAs of key regulators
of LDLmetabolism in macrophages, such as a lipoprotein lipase
and the reverse cholesterol transporters ABCA-1 and ABCG-2,
revealed unaltered expression in insulin receptor-deficient mac-
rophages (data not shown). Consistent with these findings, we
found unaltered degradation of oxidized LDL particles in TG
macrophages from MphIRKO mice (Figure 3C). Consistent
with the unaltered expression of CD36 and CD204, these data
indicate that uptake of modified LDL particles is not altered in
the presence of macrophage-specific insulin resistance.
Moreover, analysis of cholesterol efflux in cells isolated from
control and MphIRKO mice revealed no difference in basal249
A R T I C L EFigure 3. Unaltered metabolism of modified LDL particles in insulin-resistant macrophages
A) Northern blot analysis of CD36 in IRflox/flox (WT) and Cre-transduced IRflox/flox (KO) immortalized macrophage cell lines. Cells had been left either untreated or were stim-
ulated with 100 nM insulin for 24 hr. The upper-right panel shows a Western blot analysis of CD36 expression in thioglycollate-elicited macrophages of four individual
ApoE2/2IRflox/flox (WT) and IRflox/floxLysMCre+/2 (KO) mice. The lower panel shows Western blot analysis of CD36 expression in IRflox/flox (WT) and Cre-transduced
IRflox/flox (KO) immortalized macrophage cell lines.
B) FACS analysis of CD36 surface expression in control and IR-deficient immortalized macrophage cell lines.
C) Specific uptake of oxidized LDL cholesterol in thioglycollate-elicited macrophages from IRflox/flox (WT) and IRflox/floxLysMCre+/2 (KO) mice. Data represent the mean 6
SEM of four to six animals of each genotype.
D) Cholesterol efflux in thioglycollate-elicited macrophages from control and IR-deficient mice. Cholesterol efflux was determined in the absence (open bars) and in the
presence of 10 mg/ml ApoA1 (closed bars). Data represent the mean 6 SEM of four to six animals of each genotype.acetylated LDL efflux and that after ApoA-1 stimulation
(Figure 3D). Taken together, metabolism of modified LDL parti-




To further analyze themechanism for decreased atherosclerosis
in MphIRKO mice, and to assess the inflammatory capacity of
control and IR-deficient macrophages, we determined mRNA
expression of TNF-a, MCP-1, IL-6 and IL-1b under basal condi-
tions and after LPS-stimulation. This analysis revealed that in the
basal state, both control and IR-deficient macrophages express
very little mRNA of these genes (Figure 4A). In contrast, LPS po-
tently stimulated expression of TNF-a, MCP-1, IL-6, and IL-1b
mRNA in IRflox/floxmacrophages (Figure 4A). In IR-deficient mac-
rophages LPS stimulated expression of TNF-a and MCP-1 to
similar extend as compared to control cells but almost com-250pletely failed to stimulate expression of IL-6 and IL-1b (Fig-
ure 4A). These data indicate that macrophage autonomous
insulin signaling is required for selective LPS-stimulated tran-
scription of proinflammatory cytokines such as IL-6 and IL-1b,
while insulin resistance in these cells does not influence LPS
ability to induce transcription of TNF-a and MCP-1.
To further test the functional significance of altered interleukin
transcription, we determined the release of the cytokines tested
above into the supernatant of cultured cells. Under basal condi-
tions the levels of TNF-a, MCP-1 and IL-6 were below the detec-
tion limit of the ELISA assays (Figure 4B). On the other hand, LPS
potently stimulated the release of MCP-1 and TNF-a in control
and IR-deficient macrophages, although there was a tendency
toward decreased release of TNF- a in IR-deficient macro-
phages compared to control cells (954 + 75 ng/ml versus 1137 +
58 ng/ml; p = 0.09). Strikingly, while LPS potently stimulated
the release of IL-6 into the supernatant of control cells, it com-
pletely failed to do so in IR-deficient macrophages (Figure 4B).CELL METABOLISM : APRIL 2006
Macrophage-specific insulin resistanceTo confirm these findings in a second macrophage system,
TG-elicited macrophages from control and MphIRKO mice
were analyzed for their capacity to release TNF-a and IL-6 in re-
sponse to LPS stimulation. Consistent with the results obtained
in the immortalized IR-deficient cell lines, LPS-stimulated IL-6
releasewas significantly reduced in cells derived fromMphIRKO
mice, while TNF-a release remained unaltered (Figure 4C).
Taken together, these results of a significantly reduced capacity
of LPS-stimulated IL-6 release in the presence of macrophage
autonomous insulin resistance.
Uncoupling of systemic versus hematopoetic
cell-restricted insulin resistance in atherosclerosis
To directly address the apparent difference between the clinical
association of systemic insulin resistance and atherosclerosis
on one hand and the protection from atherosclerosis as a conse-
quence ofmyeloid-specific insulin receptor deletion on the other
hand, we decided to employ another mouse model for both sys-
temic and myeloid-specific insulin resistance. Since IRS-2 rep-
resents themajor insulin receptor substrate protein expressed in
macrophages, mice lacking the insulin receptor substrate (IRS)-
2 in all tissues throughout development via conventional gene
targeting were backcrossed on an ApoE-deficient background.
Male IRS-2-deficient mice exhibited significantly increased fast-
ing blood glucose concentrations and severely impaired glu-
cose tolerance also on an ApoE-deficient background (data
not shown) as previously described for other backgrounds
(Kubota et al., 2000). Also, when exposed to high-cholesterol
diet, male IRS-2 knockout mice demonstrated severe glucose
intolerance (Figure 5A). On the other hand, plasma cholesterol
and triglyceride concentrations were indistinguishable between
control and IRS-2-deficient mice on an ApoE-deficient back-
ground when exposed to high-cholesterol diet (Figure 5C).
To directly restrict the same molecular mechanism of insulin
resistance - namely IRS-2 deficiency - to hematopoetic cells,
we performed transfers of IRS-2+/+ApoE2/2 (controls) and
IRS-22/2ApoE2/2 fetal liver cells into lethally irradiated
ApoE2/2 recipients. Thereby, only hematopoetic cells lack
functional IRS-2 expression, whereas IRS-2 expression in non-
hematopoetic cells remains unaltered on an ApoE-deficient
background. Physiological characterization of reconstituted
ApoE-deficient mice revealed, that parameters reflecting glu-
cose and lipid metabolism were indistinguishable between
mice, which received either control or IRS-2-deficient fetal liver
cells (Figures 5B and 5C).
Analysis of atherosclerotic lesions in IRS-2+/+ApoE2/2 and
IRS-22/2ApoE2/2 mice revealed that abdominal lesion area
increased 1.7fold in IRS-22/2ApoE2/2 mice compared to
IRS-2+/+ApoE2/2 mice (Figure 6A). Similarly, lesion area in the
aortic arch increased from 32% in IRS-2+/+ApoE2/2 mice to
52% in IRS-22/2ApoE2/2 mice (Figure 6B) and lesion area in
cross-sections of the aortic root increased from 150.000 to
250.000 mm2 (Figure 6C). Taken together, these data indicate
that systemic insulin resistance and impaired glucose tolerance
due to IRS-2 deficiency aggravate atherosclerosis in ApoE-
deficient mice.
On the other hand, analysis of atherosclerotic lesions in the re-
constituted ApoE-deficientmice revealed a significant reduction
in plaque formation in the aortic arch and in the aortic root of
mice receiving IRS-2-deficient FLC (Figures 7A and 7B). Taken
together, these data directly uncouple the role of systemic ver-CELL METABOLISM : APRIL 2006sus hematopoetic lineage-restricted insulin resistance in the de-
velopment of atherosclerosis by demonstrating that the same
genetic defect when present systemically aggravates athero-
sclerosis while when only restricted to hematopoetic cells pro-
tects from the development of atherosclerosis.
Discussion
In summary, our data provide direct evidence for a proinflamma-
tory role of cell autonomous insulin action in macrophages. The
reduced capacity of IR-deficient macrophages to express IL-6
and IL-1b and to secrete IL-6 provides a potential mechanism
by which myeloid lineage-specific insulin resistance may atten-
uate development of atherosclerosis in ApoE-deficient mice.
Moreover, these data are consistent with previous studies
showing enhanced development of atherosclerosis in control
and ApoE-deficient mice after injection of IL-6 and protection
from bacterial and high fat diet-induced atherosclerosis in
ApoE+/2 mice by deletion of the IL1 receptor gene (Chi et al.,
2004; Huber et al., 1999). Although the animals examined in
the present study had only aw90% contribution of C57Bl6J al-
leles and since genetic background heterogeneity can influence
atherosclerosis studies, protection from atherosclerosis in two
independent models (MphIRKO mice and IRS-22/2ApoE2/2
transplantation) supports the notion that myeloid-restricted
insulin resistance protects from the development of athero-
sclerosis.
These findings may seem somewhat surprising in view of the
fact that insulin-resistant patients with type 2 diabetes exhibit an
increased risk for the development of atherosclerosis. However,
this likely relates to the multifactorial nature of atherosclerosis.
First, it is not clear to what extend macrophages in diabetes ex-
hibit insulin resistance. In humans it remains controversial
whether IR-expression in monocytes is decreased in diabetic
patients. While decreased insulin binding to circulating mono-
cytes in both diabetic and obese insulin-resistant patients has
been described, others studies revealed unaltered binding but
impaired internalization of insulin receptors in these cells (Kelly
and Fantus, 1995); (Mandarino et al., 1984); (Trischitta et al.,
1989). Studies have also demonstrated impaired insulin and
IGF-1-stimulated IRS-2 tyrosine phosphorylation in a murine
model of diet induced obesity and in genetically obese and insu-
lin-resistant ob/ob mice and impaired insulin-stimulated IRS-2
phosphorylation after incubation of cultured macrophages in
the presence of elevated insulin concentrations (Hartman
et al., 2004; Liang et al., 2004). Nevertheless, in patients with
type 2 diabetes, hyperinsulinemia might overcome reduced
macrophage insulin signaling leading to constant proinflam-
matory signaling predisposing for the development atheroscle-
rosis. Alternatively, although macrophage-autonomous insulin
resistance provides a protective factor for the development of
atherosclerosis, insulin resistance in other tissues leading to
elevated blood pressure, decreased concentrations of HDL-
cholesterol and increased concentrations of VLDL-cholesterol
may override this protective effect. Indeed this notion is sup-
ported by the IRS-2-deficient mousemodels used in the present
study, unraveling the contrasting effect of systemic versus hema-
topoetic cell-restricted insulin resistance in the development of
atherosclerosis. Thus, further analysis of interactions between
these multiple molecular mechanisms engaged in insulin’s
proinflammatory action in macrophages may help to develop251
A R T I C L EFigure 4. Impaired inflammatory response in insulin-resistant macrophages
A) Northern blot analysis of MCP1, TNF-a, IL-1b, and IL-6 expression in IRflox/flox immortalized macrophage cell lines treated without (WT) or with HNTC-Cre (KO), which
have been cultured either in the absence or presence of 10 ng/ml LPS for 24 hr. The lower panel shows the densitometric quantitation ofmRNA-expression obtained in three
independent experiments. Signal intensity detected in unstimulated WT cells was set as 1. Data represent the mean 6 SEM (**p < 0.01 in unpaired Student’s t test).
B) Amount of the indicated cytokines released into the culture medium by control or IR-deficient immortalizedmacrophages, which had been cultured either in the absence
or presence of 10 ng/ml LPS for 3 days. Data represent the mean 6 SEM obtained in three independent experiments (**p < 0.01 in unpaired Student’s t test).252 CELL METABOLISM : APRIL 2006
Macrophage-specific insulin resistanceFigure 5. Metabolic characterization of IRS-2-deficient mice on an ApoE-deficient background
A) Glucose-tolerance tests were performed at the age of 12 weeks in IRS-2+/+ApoE2/2 (square) and IRS-22/2ApoE2/2 (diamond) male mice. Data represent the mean 6
SEM of 10–14 animals of each genotype.
B) Glucose-tolerance tests in male ApoE-deficient mice which have been reconstituted after lethal irradiation with either IRS-2+/+ApoE2/2 (square) or IRS-22/2ApoE2/2
(diamond) fetal liver cells. Glucose-tolerance test was performed 10 weeks after transplantation. Data represent the mean 6 SEM of 12–13 animals in each group.
C) Plasma triglyceride and cholesterol concentrations in the different mutant mice. Concentrations of triglyceride and cholesterol were determined in serum obtained from
IRS-2+/+ApoE2/2 and IRS-22/2ApoE2/2 mice at the age of 12 weeks, after 9 weeks of exposure to Western diet. Plasma cholesterol and triglyceride concentrations in
irradiated and reconstituted IRS/ApoE-deficient mice were determined 11 weeks after transfer, having been exposed for 8 weeks to high-cholesterol diet. Data represent
the mean 6 SEM of 8–12 mice in each group.novel therapeutic approaches for the treatment of atherosclero-




For disruption of the insulin receptor in myeloid lineage cells, IRflox mice (gen-
erated on a hybrid C57BL/6J/129sv background and backcrossed for two
generations on a C57BL/6J background) were bred with mice expressing
the Cre recombinase under control of the lysozyme (Lys) M promoter (back-
crossed for more than seven generations on a C57/bl6J background) ((Brun-
ing et al., 1998; Clausen et al., 1999). Animals were housed in a virus-free
facility on a 12 hr light/dark cycle (0700 on/1900 off) and were fed a standard
rodent chow or, when indicated, a diet containing 5% cholesterol (Teklad
88051, Harlan Winkelmann Inc., Borchen, Germany). For analysis of athero-
sclerosis development, IRflox/flox LysMCre mice (s.a.) were crossed with
ApoE-deficient mice on a C57BL/6J background obtained from Jackson lab-
oratory. Analysis of polymorphic markers revealed the expected frequency of
w90% homozygous C57BL/6J alleles in the resulting offspring (data not
shown). IRS-2-deficient mice on a mixed C57BL6J/129sv background
(Kubota et al., 2000) were backcrossed on a C57BL/6J background for
four generations and then intercrossed with ApoE-deficient mice on a
C57BL/6J background. IRS-2+/2ApoE+/2 mice were intercrossed to yieldCELL METABOLISM : APRIL 2006IRS-2+/2ApoE2/2 mice, which were further intercrossed to yield littermates,
which were IRS-2+/+ApoE2/2 or IRS-22/2ApoE2/2. Genotyping was per-
formed by PCR using genomic DNA isolated from tail tips as previously
described (Bruning et al., 1998). All protocols for animal use and euthanasia
were reviewed by the animal care committee of the University of Cologne,
approved by local government authorities and were in accordance with
NIH-guidelines.
Genome scanning
Using DNA prepared from ten randomly selected experimental mice, 56
mapped microsatellite loci ((Dietrich et al., 1996); http://carbon.wi.mit.edu:
8000/cgi-bin/mouse/index), previously determined to be polymorphic in
a C57BL/6J X 129X1/SvJ (formerly 129/SvJ) cross, were analyzed using
methods adapted from Dietrich (Dietrich et al., 1992). Briefly, PCR amplifica-
tion from genomic DNA was performed using fluorochrome-labeled primers
purchased from Research Genetics, Inc. (Huntsville, AL) or synthesized from
published oligonucleotide sequences (Integrated DNA Technologies, Coral-
ville, IA). Products were separated using a 4% agarose gel and scored by
comparison to control C57BL/6J, 129X1, and F1 DNA samples. Detailed am-
plification protocols, locus list, and allele sizes are available on request.
Fetal liver cell transfers
Embryos were obtained by intercrossing IRS-2+/2ApoE2/2 mice and typed
for male gender as previously described (Bruning et al., 2000). IRS-2+/+
ApoE2/2 and IRS-22/2ApoE2/2 FLC were isolated from male embryos onC) Amount of the indicated cytokines released into the culturemedium by TG-elicited macrophages from control (WT) andMphIRKO-(KO)mice. Cells have been cultured in
the absence or presence of 10 ng/ml LPS for 3 days. Data represent the mean6 SEM obtained from cells of four mice of each genotype, each cell line assayed in triplicate
(*p < 0.05 in unpaired Student’s t test).253
A R T I C L EFigure 6. Aggravated atherosclerosis in IRS-22/2ApoE2/2 mice
A) Lesion surface area in the abdominal aorta was determined in 4-month-old IRS-2+/+ApoE2/2 and IRS-22/2ApoE2/2mice after 12 weeks of exposure to high-cholesterol
diet. The left panel demonstrates an example of the lipid-stained lesions, the graph demonstrates a quantitative assessment of lesion size in 12–22 animals in each group.
(p < 0.05 in unpaired Student’s t test).
B) Quantification of lipid-positive lesions of the aortic arch as percentage of surface. The left panel demonstrates exemplary pictures, the graph on the right side presents
the quantitative assessment of lesion size in 12–20 mice of each genotype. (p < 0.05 in unpaired Student’s t test).
C) Cross-section analysis of atherosclerotic lesions in the aortic root. Left panel demonstrates a representative result obtained in IRS-2+/+ApoE2/2 and IRS-22/2ApoE2/2
mice. The graph shows the quantitative assessment of lesion area in these animals for 10–15 animals in each genotype. (p < 0.05 in unpaired Student’s t test).day 16.5 postconception. For FLC transfer, single-cell suspensions of fetal
livers were prepared, and 106 FLC in HBSS in a volume of 300 ml were in-
jected i.v. into 8-week-old ApoE2/2C57BL/6 mice (24) that had been lethally
irradiated (900 rad) the previous day (Baudler et al., 2005). Recipients were
treated with antibiotics in the drinking water after irradiation; the mix of anti-
biotics was changed every 2 weeks (kanamycin sulfate, neomycin sulfate,
and bacitracin, or penicillin, streptomycin sulfate, and gentamycin sulfate;25430 mg/liter each) and exposed to high-cholesterol diet starting 2 weeks after
transplantation.
Quantification of atherosclerosic lesions
Quantification of atherosclerotic lesions was performed by determining
lesion surface area in the aortic arch and in the total abdominal aorta as
indicated in the figure legends. Additionally, when indicated, lesions wereCELL METABOLISM : APRIL 2006
Macrophage-specific insulin resistanceFigure 7. Adoptive transfer of IRS-2+/+ApoE2/2 and
IRS-22/2ApoE2/2 fetal liver cells protects against
atherosclerosis
Male ApoE-deficient mice were lethally irradiated at
the age of 6–8 weeks and reconstituted the following
day by iv injection of fetal liver cells obtained from
male IRS-2+/+ApoE2/2 and IRS-22/2ApoE2/2 em-
bryos. Mice were allowed to recover under normal
chow diet for 2 weeks and then exposed to high-
cholesterol diet for 12 weeks before analysis of
atherosclerosis.
A)Quantification of lipid-positive lesions of the aortic
arch as percentage of surface. The left panel demon-
strates exemplary pictures, the graph on the right
side presents the quantitative assessment of lesion
size in 17–22 mice of each genotype. (p < 0.05 in
unpaired Student’s t test).
B) Cross-section analysis of atherosclerotic lesions
in the aortic root. Left panel demonstrates a repre-
sentative result, the graph shows the quantitative
assessment of lesion area in these animals for 14–
15 animals in each genotype. (p < 0.05 in unpaired
Student’s t test).quantified in cross-sections obtained at the level of the aortic valve. Proce-
dures were performed as previously described (Makowski et al., 2001).
Cell lines and primary cultured cells
To immortalize control and IR-deficient macrophage cell lines with inducible
deletion of the insulin receptor, IRflox/flox mice were sacrificed and bone mar-
row cells were isolated. Cells were transducedwith a v-myc/v-raf-expressing
retrovirus as previously described (Mukhopadhyay et al., 2001). Cell lines de-
rived from IRflox/flox mice were transduced with a recombinant fusion protein
of the Cre-recombinase and the HIV-Tat protein transduction domain
(HNTC), allowing for efficient fusion protein-mediated recombination and
IR inactivation. HNTC transduction was performed as previously described
(Peitz et al., 2002).
Immunoprecipitations and Western blot analysis
Tissues were removed and homogenized in homogenization buffer (50 mM
HEPES [pH 7.4], 1% Triton X-100, 50 mM sodium pyrophosphate, 0.1 M
sodium fluoride, 10mMEDTA, 10mMsodium orthovanadate, 10 mg/ml apro-
tinin, 10 mg/ml leupeptin, 2 mM benzamidine, and 2 mM PMSF) with a Poly-
tron homogenizer. Samples were allowed to solubilize for 30 min on ice, and
particulate matter was removed by centrifugation at 42,000 rpm for 1 hr at
4ºC in a Sorvall centrifuge. Immunoprecipitations and Western blot of insulin
signaling proteins were performed as previously described (Bruning et al.,
1998).
Northern blot
Total RNA from macrophages was prepared using Trizol RNA extraction
reagent according to the manufacturer’s guidelines. RNA gels, blots, and
hybridizations with radiolabeled cDNA-probes were performed as previously
described (Bruning et al., 1998).
Analytical procedures
Blood glucose values were determined from whole venous blood using an
automatic glucose monitor (Glucometer Elite, Bayer). Insulin and leptin levelsCELL METABOLISM : APRIL 2006in serumweremeasured by ELISA usingmouse standards according toman-
ufacturer’s guidelines (Crystal Chem., Downers Grove, IL). Serum cholesterol
and triglyceride determinations were performed on a Beckmann CX7 ana-
lyzer. Lipoprotein profiles were determined by FPLC analysis as previously
described (Makowski et al., 2001).
Glucose-tolerance and insulin-tolerance tests were performed on animals
that had been fasted overnight for 16 hr. Animals were injected with either
2 g/kg body weight of glucose or 0.75 U/kg body weight of human regular
insulin (Novo Nordisk Pharmaceuticals Inc., Princeton, NJ) into the peritoneal
cavity. Glucose levels were determined in blood collected from the tail tip
immediately before and 15, 30, 60, and 120 min after the injection.
Cytokine Release
Primarymacrophages or immortalizedmacrophage cell lines were incubated
with the indicated reagents for 24 hr. Supernatants were collected after 72 hr
of treatment and cytokine levels were determined by commercially available
ELISA systems (TNF-a, IL-6, IL-1b, and MCP-1 from R&D, Minneapolis, MN).
Cholesterol efflux and degradation
For the analysis of cholesterol efflux, acLDL particles were incubated for
30 min with 3H-labeled cholesterol to incorporate the radiolabel into the par-
ticles. Cells were loaded with 3H-acLDL particles for 24 hr, rested overnight
without tritiated or acLDL particles in the medium, and then efflux to increas-
ing doses of apoA1 was induced for 4 hr. For the analysis of degradation,
apoB particles were labeled with 125I. Unlabeled LDL and 125I-LDL particles
were oxidized for 18 to 24 hr. Cells were loaded with 10 mg/ml of labeled
oxLDL and 70 mg/ml unlabeled oxLDL. Degradation and efflux was calcu-
lated as previously described (Makowski et al., 2001).
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